Filing of the 2012 Registration document
Press release
Avignon, May 3rd, 2013 - Naturex, world leader in speciality plant-based ingredients, has published its registration document for the year ended December 31st, 2012.
- 2012 Registration document
The 2012 Registration document was filed with the French Financial Markets Authority (Autorité des Marchés Financiers) on April 30th, 2013 under the number D.13-0471.
This document includes :
- the annual financial report for the year ended December 31st, 2012 according to article L 451-1-2 of Code monétaire et financier ;
- the Chairman of the Board of Directors' Report on Corporate Governance, internal control and risk management ;
- the information related to the Statutory Auditors'fees ;
- the annual information document.
Copies of this document in French language are available free of charge, pursuant to applicable law, and can be downloaded from the company's web site www.naturex.fr, under the « Investors » section, as well as on www.amf-france.org.
English translation of this document will be soon available.
You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com
- Financial schedule
|
29 May 2013 |
- Upcoming events
|
26 June 2013 |
Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B
 |
Total number of shares comprising the share capital: 7,816,395 ISIN FR0000054694 Naturex is a component of the CAC Small and Gaïa indexes. Naturex is eligible for the "long only" Deferred Settlement Service (SRD). Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY. |
SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY
About Naturex
Naturex is a global leader in speciality plant-based natural ingredients.
The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 1,300 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 20 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, UAE, Thailand, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).
Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.
- Contacts
|
Thierry Lambert Chairman and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 [email protected] |
Thierry Bertrand Lambert Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 [email protected] |
|
Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 [email protected] |
Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 [email protected] |
Communiqués de mise à disposition de documents :
- Modalités de mise à disposition de document de référence ou de ses actualisations
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-31918-CP-NATUREX-030513.pdf
<!-- 90 -->
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
